Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

af Thum, Thomas, Springer, Jochen
Udgivet 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

af Schanze, Nancy, Springer, Jochen
Udgivet 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

af Tschirner, Anika, Springer, Jochen
Udgivet 2012

MicroRNAs in muscle wasting

af Suzuki, Tsuyoshi, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

af Palus, Sandra, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

af Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

af Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

af Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

af Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

af Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Udgivet i ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

af Lena, Alessia, Anker, Markus S., Springer, Jochen
Udgivet i Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

af Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Udgivet 2014

Blocking myostatin: muscle mass equals muscle strength?

af Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

af Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

af Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

af Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

af Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

af Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

af Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

af Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Udgivet i J Cachexia Sarcopenia Muscle (2016)